What if aging is not simply an unavoidable decline, but a biological process we can increasingly understand—and perhaps one day control?
By Jim Sluder · The Human Infinite Project · October 2026
Introduction: Is Longevity Science Real, or Are We Being Sold a Dream?
For thousands of years, humanity has searched for ways to extend life.
Ancient civilizations imagined fountains of youth. Alchemists pursued elixirs of immortality. Modern medicine developed vaccines, antibiotics, surgical techniques, and treatments that have helped millions survive diseases that once meant almost certain death.
Today, a new scientific frontier is emerging: longevity science.
Researchers are examining whether the biological processes responsible for aging can be slowed, modified, or partially reversed. They are investigating the possibility that people might live not only longer lives but healthier, more independent, and more productive ones.
Some scientists believe these developments could eventually transform medicine. Others caution that the excitement has raced far ahead of what experiments have demonstrated.
Meanwhile, entrepreneurs promote supplements, injections, specialized clinics, and expensive treatment programs promising to restore youth or extend life.
This creates an important question for the public:
Is longevity science a legitimate scientific revolution, an exaggerated commercial opportunity, or some combination of both?
The answer is that longevity science is a legitimate research field with remarkable potential. But its most ambitious promises remain unproven.
Understanding the difference matters enormously.
After all, there is a profound difference between discovering how aging works and demonstrating that a treatment can safely make human beings live substantially longer.
1. What Exactly Is Longevity Science?
Longevity science investigates the biological, genetic, environmental, and behavioral factors that influence aging, disease, health, and lifespan.
An important branch is called geroscience.
Geroscience investigates how the biological processes of aging contribute to conditions such as:
- Heart disease and stroke
- Alzheimer’s disease and other forms of dementia
- Diabetes and metabolic disorders
- Certain cancers
- Osteoporosis and physical frailty
- Declining immune function
- Loss of muscle strength and mobility
Traditional medicine often treats these diseases individually.
Geroscience asks a different question:
What if we could address some of the underlying biological processes that make multiple diseases more likely in the first place?
Imagine repairing a deteriorating house.
Traditional medicine might repair its roof, replace damaged plumbing, and reinforce weakened walls.
Geroscience asks whether we can address the underlying processes causing several parts of the house to deteriorate.
The analogy is imperfect because human aging involves many interacting processes, but it captures the fundamental idea.
Researchers supported by the National Institutes of Health are investigating this possibility. The scientific field is real; whether particular treatments will deliver major human life extension remains an open question.
Lifespan versus healthspan
Two terms are essential.
Lifespan is the total number of years a person lives.
Healthspan is the portion of life spent in relatively good health, without substantial illness, disability, or loss of independence.
Consider two hypothetical people.
One lives to 95 but spends the final 20 years struggling with serious illness and disability.
Another lives to 92 while remaining physically active, mentally engaged, and largely independent until the final years.
Although the first person lived longer, the second experienced a longer period of healthy living.
The primary practical goal of much geroscience research is to extend healthspan and reduce the burden of age-related disease.
Extending maximum human lifespan is a more ambitious—and much less established—goal.
The first question we should ask is not simply how long we can live, but how well we can live during those additional years.
2. Is Aging a Disease, a Natural Process, or Something That Can Be Treated?
Aging has traditionally been viewed as an unavoidable biological process.
Every organism undergoes changes with time. Cells accumulate damage, tissues lose some ability to repair themselves, and many physiological systems become less resilient.
But modern research has revealed something important.
Aging is not controlled by one biological mechanism.
Instead, it involves numerous interacting processes, many of which scientists can study and experimentally influence.
A major scientific review published in Cell in 2023 identified twelve interconnected hallmarks of aging.
These include:
- Genomic instability: Damage and alterations accumulate in DNA.
- Telomere attrition: Protective structures at chromosome ends shorten or change.
- Epigenetic alterations: Chemical signals regulating gene activity change with age.
- Loss of proteostasis: Cells become less effective at maintaining and removing proteins.
- Disabled macroautophagy: Cellular recycling and cleanup systems become less efficient.
- Deregulated nutrient-sensing: Systems that respond to nutrients and energy become disrupted.
- Mitochondrial dysfunction: Cellular energy-producing structures function less effectively.
- Cellular senescence: Some damaged cells stop dividing and may contribute to inflammation.
- Stem cell exhaustion: Tissues lose some capacity to regenerate and repair.
- Altered intercellular communication: Communication between cells becomes disrupted.
- Chronic inflammation: Persistent, low-level inflammatory activity can damage tissues.
- Dysbiosis: Changes in microbial communities, including the gut microbiome, can influence health.
These hallmarks are a scientific framework, not twelve independently proven causes of human aging.
Nevertheless, they offer researchers potential targets for investigating treatments.
The fundamental discovery is that some aging-related processes can be experimentally modified.
In laboratory organisms, certain interventions can extend lifespan and improve measures of health.
But important questions remain.
Does changing one cellular process meaningfully improve an entire human body’s functioning?
Does the improvement last?
Does it prevent disease?
Can it be achieved safely?
And, most importantly, does it actually increase the number of healthy years people live?
Until those questions are answered through rigorous human research, biological promise should not be confused with clinical proof.
3. Biological Age: Are You Really as Old as Your Birthday Says?
Chronological age is simple.
It measures how many years have passed since birth.
Biological age is more complicated.
It attempts to estimate how an individual’s body is aging based on biological measurements.
Two 70-year-old individuals can have substantially different levels of cardiovascular fitness, muscle strength, metabolic health, cognitive function, and vulnerability to disease.
Researchers hope biological-age measurements can help explain these differences.
What are biological clocks?
Scientists have developed tools called biological or aging clocks.
Some examine chemical modifications to DNA, particularly DNA methylation. Others analyze blood proteins, metabolic markers, organ function, or combinations of measurements.
Artificial intelligence and statistical models can identify patterns associated with age, disease risk, or mortality.
Some clocks estimate accumulated biological aging. Others attempt to measure the current pace of aging.
But there is an important limitation.
A biological clock is an estimate, not a direct measurement of how many years someone has left to live.
Different clocks can produce different results for the same individual.
And a treatment that makes a biological-age score appear younger has not necessarily been proven to prevent disease or extend life.
For biological clocks to become reliable clinical tools, researchers must demonstrate that changes in their scores correspond to meaningful improvements in human health.
They must also establish how accurately these tools work across different ages, populations, and medical conditions.
For now, biological clocks are promising research tools, but consumers should be cautious about paying large sums for personalized claims based on a single result.
4. What Has Longevity Science Actually Accomplished?
This is where scientific evidence becomes especially important.
A. Exercise and healthy living: Strong human evidence
The most reliable ways to improve the prospects for healthy aging remain surprisingly ordinary.
Regular physical activity, including aerobic exercise and resistance training, helps preserve cardiovascular health, muscle strength, mobility, and physical independence.
Other important measures include:
- Avoiding tobacco
- Managing blood pressure, cholesterol, and diabetes
- Eating a nutritionally balanced diet
- Maintaining healthy sleep habits
- Receiving appropriate preventive healthcare
- Staying socially and mentally engaged
- Limiting harmful alcohol consumption
These practices have substantial supporting human evidence.
They do not prevent every disease, guarantee a long life, or stop biological aging.
But they can meaningfully improve health outcomes.
There is also no strong basis for claiming that lifestyle accounts for a precise, overwhelming percentage of all lifespan differences. Genetics, infections, healthcare access, income, environmental exposures, childhood conditions, and chance also matter.
The most practical longevity interventions today are often the least glamorous.
That may disappoint anyone hoping for a miracle pill, but it is valuable information.
B. Calorie restriction: Interesting human findings, unanswered questions
For decades, scientists have investigated whether reducing calorie intake without causing malnutrition can influence aging.
Studies in multiple animal species have reported health or lifespan benefits, although results vary with species, genetics, and conditions.
A randomized human study known as CALERIE investigated sustained calorie restriction in healthy adults without obesity.
A 2023 analysis found a modest slowing in one DNA-based measurement of the pace of biological aging—approximately 2–3%.
However, other biological-age measurements did not show significant changes.
Most importantly, the trial did not demonstrate that participants would live longer.
Calorie restriction can also be risky, particularly for older adults vulnerable to muscle loss, frailty, or inadequate nutrition.
These findings should encourage further research, not unsupervised restrictive dieting.
C. Rapamycin: An important experimental candidate
Rapamycin is a medication that affects a biological pathway known as mTOR, which helps regulate cellular growth and responses to nutrients.
In laboratory animals, rapamycin has produced important results, including lifespan extension in mice.
These findings have made it one of the most widely discussed candidates in longevity medicine.
But translating those benefits into healthy humans is a separate challenge.
Rapamycin has legitimate medical uses, including certain transplant-related applications, but its use for general life extension remains experimental.
Potential adverse effects include infections, mouth ulcers, metabolic changes, and interactions with other medications.
Evidence that it extends lifespan in healthy humans is not established.
It should not be casually used as a personal anti-aging experiment.
D. Senolytics: Can removing damaged cells improve aging?
As people age, some cells enter a state called cellular senescence.
These cells stop dividing. Some also release inflammatory substances that may negatively affect surrounding tissues.
Scientists are testing medications called senolytics, which aim to remove selected senescent cells.
Animal studies have generated promising findings.
Human research is underway, but it remains limited.
A 2026 systematic review identified only a small number of completed human clinical studies involving senescence-targeting therapies.
Researchers still need to determine which cells should be targeted, what benefits patients experience, how long improvements last, and whether treatment produces unexpected harm.
Cellular senescence also serves beneficial purposes, including aspects of wound healing and tumor suppression.
Eliminating senescent cells indiscriminately could therefore be dangerous.
E. NAD+ boosters: Popularity has moved faster than proof
NAD+ is a molecule involved in cellular energy metabolism and numerous biological functions.
Its relationship to aging has made it a popular target for supplements and commercial treatments.
Products containing nicotinamide riboside or related compounds are frequently promoted as ways to restore youthful cellular function.
Some interventions can alter NAD-related measurements in humans.
But changing a biochemical measurement is not the same as showing that people remain healthier for longer.
Clinical evidence for major healthspan or lifespan benefits remains insufficient.
Claims that NAD+ supplements or infusions reverse aging should therefore be treated skeptically.
F. Cellular reprogramming: One of the most exciting—and uncertain—frontiers
Perhaps the most ambitious line of research involves cellular reprogramming.
Scientists have demonstrated that certain combinations of biological factors can change cellular identity and reset aspects of cellular state.
Partial reprogramming attempts to influence some age-associated cellular changes without completely erasing a cell’s specialized identity.
Experimental work suggests intriguing possibilities for tissue repair and regeneration.
However, the risks are substantial.
Uncontrolled reprogramming may interfere with cellular identity or create tumor-related concerns.
The fact that a cell can display younger molecular characteristics does not establish that an entire human organism can be safely rejuvenated.
As of October 2026, broad systemic age reversal through cellular reprogramming has not been demonstrated in humans.
Its long-term promise deserves investigation, but commercial claims of proven whole-body rejuvenation do not.
5. Why Do Treatments Work in Mice but Fail in Humans?
Animal experiments are essential to biomedical research.
They allow scientists to investigate biological mechanisms under controlled conditions and detect possible treatment effects before involving people.
But mice are not miniature humans.
Their lifespans, immune systems, metabolic characteristics, disease patterns, and responses to medication differ from ours.
An intervention that extends a mouse’s lifespan does not necessarily extend human life.
Researchers must also distinguish between different experimental outcomes.
A treatment may:
- Improve a laboratory biomarker
- Improve cellular function
- Improve physical performance
- Delay a particular disease
- Increase average lifespan in animals
- Increase maximum lifespan in animals
These are different achievements.
Evidence for one does not automatically establish the others.
Strong human studies must determine whether an intervention produces meaningful clinical benefits.
This often requires carefully designed randomized controlled trials, appropriate comparison groups, sufficiently large samples, and long-term follow-up.
In longevity research, that creates an especially difficult problem.
If the outcome is human lifespan, how long must researchers wait to establish whether a treatment works?
Potentially decades.
Developing trustworthy shorter-term measurements of healthy aging is therefore a major scientific priority.
6. How Can We Separate Real Science from Commercial Hype?
Longevity has become a commercial marketplace.
The public encounters advertisements for:
- Anti-aging supplements
- Biological-age testing
- Hormone programs
- Experimental peptides
- Stem cell treatments
- NAD+ infusions
- Personalized longevity clinics
- Age-reversal programs
- Expensive rejuvenation packages
Some products may have legitimate uses for specific medical conditions.
Others are experimental.
Still others make claims that go well beyond available evidence.
Consumers should remember an important regulatory distinction.
In the United States, dietary supplements are generally not reviewed and approved by the FDA for safety and effectiveness before entering the market.
Prescription drugs undergo a different regulatory pathway, but even an FDA-approved medication is not necessarily approved or proven for longevity.
The FDA has also repeatedly warned about illegally marketed regenerative medicine products.
Stem cell therapies have legitimate, established medical applications, particularly in blood-forming cell transplantation. But that does not validate unapproved stem cell treatments promoted for general rejuvenation.
The appropriate question is not whether something sounds scientific.
It is whether the seller can demonstrate that the specific product safely delivers the specific benefit being advertised.
Warning signs of questionable longevity claims
Be especially cautious when a company:
- Promises to reverse aging or dramatically extend life
- Relies mainly on celebrity endorsements or testimonials
- Uses mouse experiments as proof of human effectiveness
- Claims a treatment has no side effects
- Describes a supplement as a cure for multiple unrelated diseases
- Refuses to identify the scientific studies behind its claims
- Uses biological-age scores as proof of additional years of life
- Demands large payments for experimental treatments
- Suggests conventional physicians are hiding a proven cure
- Markets experimental treatments as guaranteed breakthroughs
An expensive treatment is not necessarily a better treatment.
And scientific-sounding terminology is not proof.
In longevity medicine, hope is understandable. Selling certainty where uncertainty exists is not.
7. The Essential Questions Everyone Should Ask
Before accepting a longevity claim, consumers, journalists, policymakers, and researchers should ask the following questions.
About the science
- What exactly is the intervention supposed to accomplish?
- Does it target a known biological process associated with aging?
- Has that process been shown to cause age-related decline, or is it merely correlated with aging?
- Is the treatment intended to extend lifespan, improve healthspan, prevent disease, or change a biomarker?
- What biological mechanisms support the claim?
About the evidence
- Has the intervention been tested in humans?
- Were the studies randomized and appropriately controlled?
- How many people participated?
- How long were they followed?
- Were results independently replicated?
- Did participants experience meaningful health improvements?
- Were benefits measured directly or estimated through biomarkers?
- Has the treatment been shown to reduce disease, disability, or mortality?
- Were unsuccessful or negative studies also reported?
About safety
- What are the known adverse effects?
- What risks remain unknown?
- Could the treatment increase cancer risk or impair important biological functions?
- How might it interact with existing medications?
- Are older adults or people with chronic conditions especially vulnerable?
- Has long-term safety been established?
About marketing and regulation
- Is the treatment FDA-approved for the particular claimed use?
- Is it a regulated medication, an experimental intervention, or a dietary supplement?
- Who performed and funded the research?
- Does the company selling the treatment have financial conflicts of interest?
- What evidence would convince independent experts that the treatment does not work?
About society
- Who will be able to afford effective treatments?
- Will public healthcare systems provide access?
- Could longevity advances deepen existing inequalities?
- How might longer lives affect retirement, employment, housing, and families?
- Who should determine the ethical boundaries of interventions that alter human aging?
These questions help separate scientific possibility from demonstrated reality.
They also connect longevity science to larger questions about humanity’s future.
8. The Economic and Ethical Questions May Be as Important as the Biology
Suppose scientists eventually develop a safe treatment that substantially extends healthy human life.
Who receives it?
Would access depend on wealth?
Would insurance companies cover it?
Would governments consider longevity treatment preventive healthcare?
Or would it become another advantage reserved primarily for wealthy individuals?
Imagine a future in which affluent people can purchase decades of additional healthy life while poorer communities continue experiencing preventable illness and premature death.
The technology might represent a tremendous scientific achievement while simultaneously worsening social inequality.
The moral significance of extending life cannot be separated from the conditions under which people live.
A society that develops revolutionary therapies but fails to provide basic preventive healthcare has not solved the larger problem.
This raises another important issue.
Longer lives would change civilization
If healthy human lifespans eventually increase substantially, society may need to reconsider:
- Retirement and pension systems
- Career development and lifelong education
- Population and resource planning
- Intergenerational wealth and political power
- Healthcare financing
- Housing and urban development
- Family structures
- Employment opportunities across generations
- Personal identity and the meaning of life stages
A world where people routinely remain healthy for 110 or 120 years would function differently from today’s society.
But those ages are hypothetical scenarios, not scientifically established forecasts.
We must distinguish what longevity research might eventually make possible from what it has already achieved.
9. Could Artificial Intelligence Accelerate Longevity Research?
Artificial intelligence may become an increasingly important tool in aging research.
Modern biological research generates enormous volumes of information involving genetics, proteins, metabolism, cellular activity, medical imaging, and patient outcomes.
AI systems can help scientists examine relationships that might be difficult to discover through traditional methods alone.
Potential applications include:
- Drug discovery: Identifying promising compounds that influence aging-related pathways.
- Biomarker development: Finding combinations of measurements that better predict biological decline.
- Personalized medicine: Investigating why individuals age differently and respond differently to treatments.
- Clinical research: Improving trial design, identifying potential participants, and analyzing complex results.
- Disease prediction: Detecting patterns associated with elevated risks of certain age-related diseases.
- Regenerative medicine: Helping researchers understand cellular changes involved in tissue repair and reprogramming.
AI may reduce the time required for some stages of scientific discovery.
But there is an essential limitation.
An AI-generated prediction is not a clinical result.
AI can identify promising hypotheses, but experiments must establish whether they are biologically correct.
Human trials must establish whether interventions are safe and effective.
The combination of AI and biological research could accelerate progress, but it cannot eliminate the need for reliable evidence.
10. What Might Longevity Science Accomplish by 2050?
Forecasting the next 25 years of biomedical progress is inherently uncertain.
Nevertheless, examining different possibilities can help society prepare.
Best-case scenario: A major healthspan revolution
By 2050, researchers might develop treatments that safely target several mechanisms of aging.
These could delay multiple chronic conditions, improve tissue repair, preserve cognitive and physical function, and reduce years spent with serious disability.
Advances in regenerative medicine might improve recovery from certain forms of organ or tissue damage.
AI-assisted research could accelerate discoveries and improve treatment selection.
If effective therapies become widely available, more people could remain healthy and independent into later life.
A larger increase in human lifespan is possible, but far less certain than incremental improvements in disease prevention and healthspan.
Probable scenario: Gradual but meaningful medical progress
The more defensible expectation is continued progress in preventing and treating age-related illnesses.
Scientists may develop better tools for measuring aging, identify useful treatments for specific conditions, and improve combinations of preventive care.
Some experimental geroscience therapies may demonstrate meaningful benefits in selected patient groups.
Others will fail clinical trials.
Average healthy lifespan may improve in populations that benefit from these advances, but inequalities and public-health problems could limit the gains.
There is no reliable scientific basis for predicting a specific universal increase in lifespan by 2050.
Worst-case scenario: Scientific progress without public benefit
Research may encounter unexpected biological limitations.
Promising animal treatments may repeatedly fail in human trials.
Some experimental interventions could cause harmful effects.
Meanwhile, commercial hype may encourage people to spend enormous sums on ineffective or unsafe treatments.
Even if valuable technologies emerge, unequal access could prevent large portions of humanity from benefiting.
In this scenario, longevity science advances scientifically while failing to deliver its broader social promise.
The most important distinction
These are scenarios, not measured probabilities.
The best case is something to work toward.
The worst case is something to guard against.
The probable case should remain open to revision as human evidence develops.
11. What Should People Do Today?
The practical advice is straightforward.
Do not wait for a future breakthrough before taking steps that improve your chances of healthy aging.
Work with qualified healthcare professionals to manage existing medical conditions and identify relevant preventive care.
Stay physically active within your abilities. Preserve muscle strength and mobility, especially as you grow older.
Eat adequately and nutritiously. Avoid extreme diets or fasting experiments without appropriate medical guidance.
Protect your sleep.
Maintain relationships, learning, and purposeful activity.
Avoid tobacco, and be skeptical of products claiming to reverse aging through a simple supplement or injection.
When new discoveries make headlines, investigate the evidence before drawing conclusions.
And remember that good health is not determined exclusively by personal choices. Financial security, living conditions, environmental safety, and access to competent healthcare also influence how people age.
For those interested in the science, research participation through legitimate clinical trials may be worth discussing with a physician.
But experimental interventions should remain experimental until the evidence demonstrates otherwise.
12. The Bigger Question: Should Humanity Try to Control Aging?
Longevity science raises a philosophical question that reaches far beyond medicine.
For most of human history, aging has been accepted as an inevitable part of existence.
But humanity has repeatedly changed what once seemed inevitable.
We developed treatments for infections that once devastated entire communities.
We created technologies that allow people to survive conditions that previously offered little hope.
We made scientific discoveries that fundamentally changed what it means to live in the modern world.
Should aging be treated differently?
If researchers eventually discover ways to reduce the biological deterioration that produces suffering, disability, and premature death, why would humanity choose not to investigate them?
At the same time, the pursuit of longer life must not become an excuse for ignoring the quality of life people already have.
The objective should not simply be to accumulate additional birthdays.
It should be to preserve the capacity to learn, contribute, create, love, explore, and participate meaningfully in society.
And it should not become another technological revolution whose benefits are concentrated among a privileged minority.
Longevity science offers a remarkable possibility: that future generations may experience aging very differently from previous generations.
But whether that possibility becomes reality depends on scientific rigor, medical safety, economic accessibility, and responsible public policy.
Conclusion: The Science Is Real. The Promises Must Still Be Proven.
So, is longevity science real?
Yes. Unequivocally, the science of biological aging is real.
Researchers have identified important mechanisms associated with aging. Experiments have demonstrated that some of these mechanisms can be modified. In various laboratory organisms, interventions have improved health measures and extended lifespan.
Human research is beginning to test whether comparable benefits can be achieved safely and reliably.
But there is another truth.
No intervention has yet been demonstrated in rigorous human research to stop aging, reverse whole-body aging, or produce dramatic extensions of maximum human lifespan.
That distinction separates scientific reality from commercial speculation.
Aging is extraordinarily complex. Meaningful human breakthroughs may arrive gradually, unevenly, and with unexpected limitations.
Nevertheless, dismissing longevity research because some companies exaggerate its possibilities would be a mistake.
The correct response is neither blind enthusiasm nor automatic rejection.
It is informed curiosity supported by evidence.
Humanity should continue investigating how aging works, how age-related diseases can be prevented, and whether healthy life can be extended substantially.
But those advances must be evaluated honestly and made accessible fairly.
Perhaps the greatest achievement of longevity science will not be discovering how to live forever.
Perhaps it will be discovering how to give more people additional years of health, independence, dignity, and opportunity.
And that leads us to the most important question of all:
If humanity eventually gains the power to significantly extend healthy human life, will we possess the wisdom to ensure that opportunity belongs to everyone?
The Human Infinite Project — Exploring artificial intelligence, human evolution, and the future we choose to create.
Evidence guide: What is established as of October 2026?
| Area | Where the evidence stands | What it means |
|---|---|---|
| Healthy lifestyle and prevention | Strong human evidence | Physical activity, management of cardiovascular risks, and preventive care improve important health outcomes. They do not prove that aging itself has been stopped. |
| Calorie restriction | Limited human evidence | A randomized trial detected modest changes in one biological aging measure, without demonstrating longer human life. |
| Rapamycin and mTOR targeting | Experimental for longevity | Strong animal interest, but lifespan benefits in healthy humans have not been established. |
| Senolytics | Early clinical research | Only a small collection of completed human studies; convincing evidence of lifespan extension is absent. |
| NAD+ supplements | Longevity claims unproven | Human results remain limited and mixed; biochemical changes do not establish longer life. |
| Cellular reprogramming | Early-stage frontier | Intriguing laboratory biology, but no proven systemic human age-reversal treatment. |
| Commercial age-reversal treatments | Claims require scrutiny | Be particularly cautious with unapproved regenerative products and treatments marketed without convincing clinical evidence. |
Selected scientific sources and further reading
The article draws on peer-reviewed research and primary scientific and regulatory sources:
- National Institute on Aging — Geroscience Interest Group. Explains the scientific foundation of geroscience.
- Hallmarks of Aging: An Expanding Universe. Cell, 2023. The twelve-hallmark biological framework.
- CALERIE Trial — Calorie Restriction and Biological Aging. Nature Aging, 2023.
- Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease. Proceedings of a National Institute on Aging workshop.
- Clinical Evidence for Rapamycin in Healthy Adults. Aging, 2025.
- Human Clinical Trials of Senescence-Targeting Therapies. Systematic review, October 2026.
- Do We Actually Need Aging Clocks? Scientific examination of biological-age measurement limitations.
- FDA — Consumer Information on Regenerative Medicine Treatments.
Keep exploring
More on longevity at The Human Infinite Project
- Longevity: AI and the science of living longer: the latest news, real vs. hype
- Longevity Escape Velocity: a free plain-language guide
- Join the conversation in the Longevity and the Human Lifespan forum room
This article is for general education, not medical advice. Talk with your doctor before changing medicines, supplements or your health routine.